Bradley and Daroffs Neurology in Clinical Practice

01
02
03
	Bradley and Daroff's Neurology in Clinical Practice (8th Edition)-2022.pdf (p.1-2875)
		i - 0
		ii - 1
		ii - 2
		ii - Dedication
			Dedication
		iii Volume I - Front Matter of Volume I
			BRADLEY and DAROFF’S NEUROLOGY in Clinical Practice
		iii Volume II - Front Matter of Volume II
			BRADLEY and DAROFF’S NEUROLOGY in Clinical Practice
		iv - Copyright
			copyright
		v - content
			id=b1slEAAAQBAJ&pg=RA1-PR5&img=1&zoom=3&hl=en&sig=ACfU3U1TOIwnV
			id=b1slEAAAQBAJ&pg=RA1-PR6&img=1&zoom=3&hl=en&sig=ACfU3U2Ci7wv1
			id=b1slEAAAQBAJ&pg=RA1-PR7&img=1&zoom=3&hl=en&sig=ACfU3U2NgFZJX
		viii - Preface
			PREFACE
		x - List of Contributors
			LIST OF CONTRIBUTORS
		xx -
		1 - 1 - Diagnosis of Neurological Disease
			1 - Diagnosis of Neurological Disease
		8 - 2 – Episodic Impairment of Consciousness
			2 - Episodic Impairment of Consciousness
				SYNCOPE
					History and Physical Examination
					Causes of Syncope
					Investigations of Patients with Syncope
				SEIZURES
					Pathophysiology
					History and Physical Examination
				SEIZURE CLASSIFICATION
					Absence Seizures
					Tonic-Clonic Seizures
					Complex Partial Seizures
					Investigations of Seizures
					Psychogenic Nonepileptic Spells
				MISCELLANEOUS CAUSES OF ALTERED CONSCIOUSNESS
				REFERENCES
		17 - 3 - Falls and Drop Attacks
			3 - Falls and Drop Attacks
				FALLS AND DROP ATTACKS—INTRODUCTION
		23 - 4 - Delirium
			4 - Delirium
				CLINICAL CHARACTERISTICS
		34 - 5 - Stupor and Coma
		52 - 6 - Prolonged Comatose States and Brain Death
		58 - 7 - Intellectual and Memory Impairments
		67 - 8 - Global Developmental Delay and Regression
			8 - Global Developmental Delay and Regression
				TYPICAL AND ATYPICAL DEVELOPMENT
		75 - 9 - Behavior and Personality Disturbances
			9 - Behavior and Personality Disturbances
		97 - 10 - Depression and Psychosis in Neurological Practice
			10 - Depression and Psychosis in Neurological Practice
				PRINCIPLES OF DIFFERENTIAL DIAGNOSIS
		120 - 11 - Limb Apraxias and Related Disorders
		127 - 12 - Agnosias
			12 - Agnosias
				VISUAL AGNOSIAS
		133 - 13 - Aphasia and Aphasic Syndromes
			13 - Aphasia and Aphasic Syndromes
		149 - 14 - Dysarthria and Apraxia of Speech
			14 - Dysarthria and Apraxia of Speech
				MOTOR SPEECH DISORDERS
		152 - 15 - Neurogenic Dysphagia
		164 - 16 - Neuro-Ophthalmology_ Afferent Visual System
		191 - 17 - Pupillary and Eyelid Abnormalities
			17 - Pupillary and Eyelid Abnormalities
				PUPILLARY ABNORMALITIES
		201 - 18 - Neuro-ophthalmology_ Ocular Motor System
			18 - Neuro-ophthalmology: Ocular Motor System
				GENERAL PRINCIPLES OF OCULAR MOTOR CONTROL
				EYE MOVEMENT ANATOMY
		241 - 19 - Disturbances of Smell and Taste
			19 - Disturbances of Smell and Taste
				ANATOMY AND PHYSIOLOGY
		248 - 20 - Cranial and Facial Pain
		255 - 21 - Brainstem Syndromes
			21 -  Brainstem Syndromes
				OCULAR MOTOR SYNDROMES
		267 - 22 - Neuro-Otology_ Diagnosis and Management of Neuro-Otological Disorders
			22 -  Neuro-Otology: Diagnosis and Management of Neuro-Otological Disorders
				HISTORICAL BACKGROUND
		288 - 23 - Cerebellar Ataxia
			23 -  Cerebellar Ataxia
		310 - 24 - Diagnosis and Assessment of Parkinson Disease and Other Movement Disorders
			24 -  Diagnosis and Assessment of Parkinson Disease and Other Movement Disorders
		334 - 25 - Gait Disorders
			25 -  Gait Disorders
		345 - 26 – Hemiplegia and Monoplegia
			26 - Hemiplegia and Monoplegia
				ANATOMY AND PHYSIOLOGY
		356 - 27 - Paraplegia and Spinal Cord Syndromes
			27 -  Paraplegia and Spinal Cord Syndromes
		362 - 28 - Proximal, Distal, and Generalized Weakness
			28 -  Proximal, Distal, and Generalized Weakness
		379 - 29 - Muscle Pain and Cramps
			29 -  Muscle Pain and Cramps
		388 - 30 - Hypotonic (Floppy) Infant
			30 -  Hypotonic (Floppy) Infant
		397 - 31 - Sensory Abnormalities of the Limbs, Trunk, and Face
			31 -  Sensory Abnormalities of the Limbs, Trunk, and Face
				ANATOMY AND PHYSIOLOGY
		407 - 32 - Arm and Neck Pain
			32 -  Arm and Neck Pain
				CLINICAL ASSESSMENT
		417 - 33 - Lower Back and Lower Limb Pain
			33 -  Lower Back and Lower Limb Pain
				ANATOMY AND PHYSIOLOGY
				APPROACH TO DIAGNOSIS OF LOW BACK AND LEG PAIN
		427 - Investigations in the Diagnosis and Management of Neurological Disease
			34 - Investigations in the  Diagnosis and Management of Neurological Disease
				DIAGNOSTIC YIELD OF ANCILLARY TESTS
				INTERPRETATION OF RESULTS OF INVESTIGATIONS
				RELIABILITY OF INVESTIGATIONS
				DECISION ANALYSIS
				RESEARCH INVESTIGATIONS AND TEACHING HOSPITALS
				PATIENT CONFIDENTIALITY
		430 - 35 - Electroencephalography and Evoked Potentials
			35 -  Electroencephalography and Evoked Potentials
		447 - 36 - Clinical Electromyography
			36 -  Clinical Electromyography
				NERVE CONDUCTION STUDIES
		472 - 37 - Extracranial Neuromodulation
			37 -  Extracranial Neuromodulation
		483 - 38 - Intracranial Neuromodulation
			38 - Intracranial Neuromodulation
		492 - 39 - Intraoperative Monitoring
			39 -  Intraoperative Monitoring
		496 - 40 - Structural Imaging Using Magnetic Resonance Imaging and Computed Tomography
			40 -  Structural Imaging Using Magnetic Resonance Imaging and Computed Tomography
		547 - 41 - Vascular Imaging_ Computed Tomographic Angiography, Magnetic Resonance Angiography, and Ultrasound
			41 -  Vascular Imaging: Computed Tomographic Angiography, Magnetic Resonance Angiography, and Ultrasound
				COMPUTED TOMOGRAPHIC ANGIOGRAPHY
		576 - 42 - Functional and Molecular Neuroimaging
			42 -  Functional and Molecular Neuroimaging
		601 - 43 - Ocular Functional and Structural Investigations
			43 -  Ocular Functional and Structural Investigations
		614 - 44 - Neuropsychology
			44 -  Neuropsychology
		633 - 45 - Neurourology
			45 - Neurourology
		652 - 46 - Sexual Dysfunction in Neurological Disorders
			46 -  Sexual Dysfunction in Neurological Disorders
		666 - 47 - Neuroepidemiology
			47 -  Neuroepidemiology
		681 - 48 - Clinical Neurogenetics
			48 -  Clinical Neurogenetics
				GENETICS IN CLINICAL NEUROLOGY
		709 - 49 - Neuroimmunology
			49 -  Neuroimmunology
				IMMUNE SYSTEM
		730 - 50 - Neuroendocrinology
			50 -  Neuroendocrinology
		748 - 51 - Management of Neurological Disease
			51 -  Management of Neurological Disease
		753 - 52 - Pain Management
			52 -  Pain Management
				DEFINITION AND CHALLENGE
		776 - 53 - Neurointensive Care
			53 -  Neurointensive Care
		793 - 54 - Principles of Neuroendovascular Therapy
			54 -  Principles of Neuroendovascular Therapy
		819 - 55 - Neurological Rehabilitation
			B -  Neurological Complications of Systemic Disease
				55 -  Neurological Rehabilitation
		850 - 56 - Transition to Adult Care for Youth with Chronic Neurological Disorders
		856 - 57 - Palliative and End-of-Life Care in Neurological Disease
			57 -  Palliative and End-of-Life Care in Neurological Disease
		862 - 58 - Neurological Complications of Systemic Disease_ Adults_
			58 - Neurological Complications of Systemic Disease: Adults*
		882 - 59 - Neurological Complications of Systemic Disease_ Children
			59 -  Neurological Complications of Systemic Disease: Children
		897 - 60 - Basic Neuroscience of Neurotrauma
			60 -  Basic Neuroscience of Neurotrauma
		907 - 61 - Concussion in Sports and Performance
			61 -  Concussion in Sports and Performance
		914 - 62 – Craniocerebral Trauma
			62 - Craniocerebral Trauma
		929 - 63 - Spinal Cord Trauma
			63 - Spinal Cord Trauma
				EPIDEMIOLOGY
		950 - 64 - Trauma of the Nervous System_ Peripheral Nerve Trauma
			64 - Trauma of the Nervous System: Peripheral Nerve Trauma
		964 - 65 - Ischemic Cerebrovascular Disease
			65 - Ischemic Cerebrovascular Disease
		1014 - 66 - Intracerebral Hemorrhage
			66 - Intracerebral Hemorrhage
		1031 - 67 - Intracranial Aneurysms and Subarachnoid Hemorrhage
			67 - Intracranial Aneurysms and Subarachnoid Hemorrhage
				EPIDEMIOLOGY
		1044 - 68 - Stroke in Children
			68 - Stroke in Children
		1058 - 69 - Spinal Cord Vascular Disease
			69 - Spinal Cord Vascular Disease
		1066 - 70 - Central Nervous System Vasculitis
			70 -  Central Nervous System Vasculitis
		1068 - 71 - Epidemiology of Brain Tumors
			71 - Epidemiology of Brain Tumors
		1076 - 72 - Pathology and Molecular Genetics
			72 - Pathology and Molecular Genetics
		1099 - 73 - Clinical Features of Brain Tumors and Complications of Their Treatment
			73 - Clinical Features of Brain Tumors and Complications of Their Treatment
		1105 - 74 - Primary Nervous System Tumors in Adults
			74 - Primary Nervous System Tumors in Adults
				GENERAL ASPECTS
		1122 - 75 - Primary Nervous System Tumors in Infants and Children
			75 - Primary Nervous System Tumors in Infants and Children
		1145 - 76 - Nervous System Metastases
			76 - Nervous System Metastases
				BRAIN METASTASES
		1165 - 77 - Neurological Manifestations of Human Immunodeficiency Virus Infection in Adults
			77 - Neurological Manifestations of Human Immunodeficiency Virus Infection in Adults
				EPIDEMIOLOGY AND CURRENT TRENDS
		1184 - 78 - Viral Encephalitis and Meningitis
			78 - Viral Encephalitis and Meningitis
		1214 - 79 - Bacterial, Fungal, and Parasitic Diseases of the Nervous System
			79 - Bacterial, Fungal, and Parasitic Diseases of the Nervous System
		1226 - 80 - Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System
			80 - Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System
		1255 - 81 - Paraneoplastic Disorders of the Nervous System
			81 - Paraneoplastic Disorders of the Nervous System
		1263 - 82 - Autoimmune Encephalitis with Antibodies to Cell Surface Antigens
			82 - Autoimmune Encephalitis with Antibodies to Cell Surface Antigens
		1269 - 83 - Anoxic-Ischemic Encephalopathy
			83 - Anoxic-Ischemic Encephalopathy
				PATHOPHYSIOLOGICAL CONCEPTS
		1276 - 84 - Toxic and Metabolic Encephalopathies
			84 - Toxic and Metabolic Encephalopathies
		1291 - 85 - Deficiency Diseases of the Nervous System
			85 - Deficiency Diseases of the Nervous System
				COBALAMIN (VITAMIN B12)
		1302 - 86 - Effects of Toxins and Physical Agents on the Nervous System
			86 - Effects of Toxins and Physical Agents on the Nervous System
		1319 - 87 - Effects of Drug Abuse on the Nervous System
			87 - Effects of Drug Abuse on the Nervous System
				DRUGS OF DEPENDENCE
		1327 - 88 - Brain Edema and Disorders of Cerebrospinal Fluid Circulation
			88 - Brain Edema and Disorders of Cerebrospinal Fluid Circulation
		1345 - 89 - Developmental Disorders of the Nervous System
			89 - Developmental Disorders of the Nervous System
		1366 - 90 - Autism and Other Neurodevelopmental Disabilities
			90 -  Autism and Other Neurodevelopmental Disabilities
		1386 - 91 - Inborn Errors of Metabolism and the Nervous System
			91 -  Inborn Errors of Metabolism and the Nervous System
		1407 - 92 - Neurodegenerative Disease Processes
			92 - Neurodegenerative Disease Processes
				WHERE DO NEURODEGENERATIVE DISORDERS BEGIN?
		1415 - 93 - Mitochondrial Disorders
			93 - Mitochondrial Disorders
		1430 - 94 - Prion Diseases
			94 -  Prion Diseases
		1452 - 95 - Alzheimer Disease and Other Dementias
			95 -  Alzheimer Disease and Other Dementias
		1498 - 96 - Parkinson Disease and Other Movement Disorders
			96 -  Parkinson Disease and Other Movement Disorders
		1535 - 97 - Disorders of Upper and Lower Motor Neurons
			97 -  Disorders of Upper and Lower Motor Neurons
		1568 - 98 - Channelopathies_ Episodic and Electrical Disorders of the Nervous System
			98 -  Channelopathies: Episodic and Electrical Disorders of the Nervous System
		1589 - 99 – Neurocutaneous Syndromes
			99 - Neurocutaneous Syndromes
		1614 - 100 – Epilepsies
			100 - Epilepsies
		1664 - 101 - Sleep and Its Disorders
			101-  Sleep and Its Disorders
		1745 - 102 - Headache and Other Craniofacial Pain
			102 -  Headache and Other Craniofacial Pain
				PAIN TRANSMISSION AND MODULATION AS RELATED TO HEADACHE
		1783 - 103 - Cranial Neuropathies
			103 -  Cranial Neuropathies
				OLFACTORY NERVE (CRANIAL NERVE I)
		1798 - 104 - Disorders of Bones, Joints, Ligaments, and Meninges
			104 -  Disorders of Bones, Joints, Ligaments, and Meninges
		1829 - 105 - Disorders of Nerve Roots and Plexuses
			105 -  Disorders of Nerve Roots and Plexuses
				DISORDERS OF NERVE ROOTS
		1853 - 106 - Disorders of Peripheral Nerves
			106 - Disorders of Peripheral Nerves
				CLINICAL APPROACH TO DISORDERS OF PERIPHERAL NERVES
		1930 - 107 - Disorders of the Autonomic Nervous System
			107 -  Disorders of the Autonomic Nervous System
		1958 - 108 - Disorders of Neuromuscular Transmission
			108 -  Disorders of Neuromuscular Transmission
		1978 - 109 - Disorders of Skeletal Muscle
			109 - Disorders of Skeletal Muscle
		2022 - 110 – Neurological Problems in the Newborn
			110 - Neurological Problems in the Newborn
		2040 - 111 - Cerebral Palsy
			111 -  Cerebral Palsy
		2049 - 112 - Neurological Problems of Pregnancy
			112 - Neurological Problems of Pregnancy
				NEUROLOGICAL COMPLICATIONS OF CONTRACEPTION
		2076 - 113 - Functional and Dissociative Neurological Symptoms and Disorders
			113 -  Functional and Dissociative Neurological Symptoms and Disorders
		2093 - index
			Index M
				id=b1slEAAAQBAJ&pg=RA2-PA101&img=1&zoom=3&hl=en&sig=ACfU3U1RYwg
				id=b1slEAAAQBAJ&pg=RA2-PA102&img=1&zoom=3&hl=en&sig=ACfU3U1mpHZ
				id=b1slEAAAQBAJ&pg=RA2-PA103&img=1&zoom=3&hl=en&sig=ACfU3U0w7TO
				id=b1slEAAAQBAJ&pg=RA2-PA104&img=1&zoom=3&hl=en&sig=ACfU3U2vTLC
				id=b1slEAAAQBAJ&pg=RA2-PA105&img=1&zoom=3&hl=en&sig=ACfU3U1XLr6
				id=b1slEAAAQBAJ&pg=RA2-PA106&img=1&zoom=3&hl=en&sig=ACfU3U03niJ
				id=b1slEAAAQBAJ&pg=RA2-PA107&img=1&zoom=3&hl=en&sig=ACfU3U2_b4M
				id=b1slEAAAQBAJ&pg=RA2-PA108&img=1&zoom=3&hl=en&sig=ACfU3U2L1tN
				id=b1slEAAAQBAJ&pg=RA2-PA109&img=1&zoom=3&hl=en&sig=ACfU3U0m-XR
				id=b1slEAAAQBAJ&pg=RA2-PA110&img=1&zoom=3&hl=en&sig=ACfU3U232j8
				id=b1slEAAAQBAJ&pg=RA2-PA111&img=1&zoom=3&hl=en&sig=ACfU3U1_TCg
				id=b1slEAAAQBAJ&pg=RA2-PA112&img=1&zoom=3&hl=en&sig=ACfU3U3e0yB
				id=b1slEAAAQBAJ&pg=RA2-PA113&img=1&zoom=3&hl=en&sig=ACfU3U3QqZc
				id=b1slEAAAQBAJ&pg=RA2-PA114&img=1&zoom=3&hl=en&sig=ACfU3U059db
				id=b1slEAAAQBAJ&pg=RA2-PA115&img=1&zoom=3&hl=en&sig=ACfU3U024iz
				id=b1slEAAAQBAJ&pg=RA2-PA116&img=1&zoom=3&hl=en&sig=ACfU3U3_6cb
				id=b1slEAAAQBAJ&pg=RA2-PA117&img=1&zoom=3&hl=en&sig=ACfU3U354qs
				id=b1slEAAAQBAJ&pg=RA2-PA118&img=1&zoom=3&hl=en&sig=ACfU3U3F5da
				id=b1slEAAAQBAJ&pg=RA2-PA119&img=1&zoom=3&hl=en&sig=ACfU3U1gWX1
				id=b1slEAAAQBAJ&pg=RA2-PA120&img=1&zoom=3&hl=en&sig=ACfU3U32Bx8
				id=b1slEAAAQBAJ&pg=RA2-PA121&img=1&zoom=3&hl=en&sig=ACfU3U0Ke-5
				id=b1slEAAAQBAJ&pg=RA2-PA122&img=1&zoom=3&hl=en&sig=ACfU3U0zraB
				id=b1slEAAAQBAJ&pg=RA2-PA123&img=1&zoom=3&hl=en&sig=ACfU3U1xKvX
				id=b1slEAAAQBAJ&pg=RA2-PA124&img=1&zoom=3&hl=en&sig=ACfU3U2409I
				id=b1slEAAAQBAJ&pg=RA2-PA125&img=1&zoom=3&hl=en&sig=ACfU3U2-Zsl
				id=b1slEAAAQBAJ&pg=RA2-PA126&img=1&zoom=3&hl=en&sig=ACfU3U1ht3e
				id=b1slEAAAQBAJ&pg=RA2-PA127&img=1&zoom=3&hl=en&sig=ACfU3U2RK-J
				id=b1slEAAAQBAJ&pg=RA2-PA128&img=1&zoom=3&hl=en&sig=ACfU3U1G-7S
				id=b1slEAAAQBAJ&pg=RA2-PA129&img=1&zoom=3&hl=en&sig=ACfU3U2SWJj
				id=b1slEAAAQBAJ&pg=RA2-PA130&img=1&zoom=3&hl=en&sig=ACfU3U2JDld
				id=b1slEAAAQBAJ&pg=RA2-PA131&img=1&zoom=3&hl=en&sig=ACfU3U1hjKP
				id=b1slEAAAQBAJ&pg=RA2-PA132&img=1&zoom=3&hl=en&sig=ACfU3U0ty9L
				id=b1slEAAAQBAJ&pg=RA2-PA133&img=1&zoom=3&hl=en&sig=ACfU3U3oM2F
				id=b1slEAAAQBAJ&pg=RA2-PA134&img=1&zoom=3&hl=en&sig=ACfU3U1LD-C
				id=b1slEAAAQBAJ&pg=RA2-PA135&img=1&zoom=3&hl=en&sig=ACfU3U36EMS
				id=b1slEAAAQBAJ&pg=RA2-PA136&img=1&zoom=3&hl=en&sig=ACfU3U1AOCq
				id=b1slEAAAQBAJ&pg=RA2-PA137&img=1&zoom=3&hl=en&sig=ACfU3U034KR
				id=b1slEAAAQBAJ&pg=RA2-PA138&img=1&zoom=3&hl=en&sig=ACfU3U0fqEn
				id=b1slEAAAQBAJ&pg=RA2-PA139&img=1&zoom=3&hl=en&sig=ACfU3U22VEd
				id=b1slEAAAQBAJ&pg=RA2-PA140&img=1&zoom=3&hl=en&sig=ACfU3U2fisG
				id=b1slEAAAQBAJ&pg=RA2-PA141&img=1&zoom=3&hl=en&sig=ACfU3U1atRL
				id=b1slEAAAQBAJ&pg=RA2-PA142&img=1&zoom=3&hl=en&sig=ACfU3U1V55a
				id=b1slEAAAQBAJ&pg=RA2-PA143&img=1&zoom=3&hl=en&sig=ACfU3U0JrXN
				id=b1slEAAAQBAJ&pg=RA2-PA144&img=1&zoom=3&hl=en&sig=ACfU3U1sky7
				id=b1slEAAAQBAJ&pg=RA2-PA145&img=1&zoom=3&hl=en&sig=ACfU3U0emIz
				id=b1slEAAAQBAJ&pg=RA2-PA146&img=1&zoom=3&hl=en&sig=ACfU3U2WKcP
				id=b1slEAAAQBAJ&pg=RA2-PA147&img=1&zoom=3&hl=en&sig=ACfU3U2O9AZ
				id=b1slEAAAQBAJ&pg=RA2-PA148&img=1&zoom=3&hl=en&sig=ACfU3U30yOB
				id=b1slEAAAQBAJ&pg=RA2-PA149&img=1&zoom=3&hl=en&sig=ACfU3U2GtZ8
				id=b1slEAAAQBAJ&pg=RA2-PA150&img=1&zoom=3&hl=en&sig=ACfU3U2Pfhc
				id=b1slEAAAQBAJ&pg=RA2-PA151&img=1&zoom=3&hl=en&sig=ACfU3U1_ncN
				id=b1slEAAAQBAJ&pg=RA2-PA152&img=1&zoom=3&hl=en&sig=ACfU3U0AjxD
				id=b1slEAAAQBAJ&pg=RA2-PA153&img=1&zoom=3&hl=en&sig=ACfU3U3zyQU
				id=b1slEAAAQBAJ&pg=RA2-PA154&img=1&zoom=3&hl=en&sig=ACfU3U1De0b
				id=b1slEAAAQBAJ&pg=RA2-PA155&img=1&zoom=3&hl=en&sig=ACfU3U3pCYd
				id=b1slEAAAQBAJ&pg=RA2-PA156&img=1&zoom=3&hl=en&sig=ACfU3U0S8kN
				id=b1slEAAAQBAJ&pg=RA2-PA157&img=1&zoom=3&hl=en&sig=ACfU3U1mANm
				id=b1slEAAAQBAJ&pg=RA2-PA158&img=1&zoom=3&hl=en&sig=ACfU3U3xqDk
				id=b1slEAAAQBAJ&pg=RA2-PA159&img=1&zoom=3&hl=en&sig=ACfU3U344ZP
				id=b1slEAAAQBAJ&pg=RA2-PA160&img=1&zoom=3&hl=en&sig=ACfU3U0qVuF
				id=b1slEAAAQBAJ&pg=RA2-PA161&img=1&zoom=3&hl=en&sig=ACfU3U3RMuQ
				id=b1slEAAAQBAJ&pg=RA2-PA162&img=1&zoom=3&hl=en&sig=ACfU3U29cxf
				id=b1slEAAAQBAJ&pg=RA2-PA163&img=1&zoom=3&hl=en&sig=ACfU3U2ZxtK
				id=b1slEAAAQBAJ&pg=RA2-PA164&img=1&zoom=3&hl=en&sig=ACfU3U2frny
				id=b1slEAAAQBAJ&pg=RA2-PA165&img=1&zoom=3&hl=en&sig=ACfU3U3BZ5C
				id=b1slEAAAQBAJ&pg=RA2-PA166&img=1&zoom=3&hl=en&sig=ACfU3U0iv3P
				id=b1slEAAAQBAJ&pg=RA2-PA167&img=1&zoom=3&hl=en&sig=ACfU3U0gXYT
				id=b1slEAAAQBAJ&pg=RA2-PA168&img=1&zoom=3&hl=en&sig=ACfU3U1WnIy
				id=b1slEAAAQBAJ&pg=RA2-PA169&img=1&zoom=3&hl=en&sig=ACfU3U3foQH
				id=b1slEAAAQBAJ&pg=RA2-PA170&img=1&zoom=3&hl=en&sig=ACfU3U0IJzr
				id=b1slEAAAQBAJ&pg=RA2-PA171&img=1&zoom=3&hl=en&sig=ACfU3U2pEDa
				id=b1slEAAAQBAJ&pg=RA2-PA172&img=1&zoom=3&hl=en&sig=ACfU3U0FGiU
				id=b1slEAAAQBAJ&pg=RA2-PA173&img=1&zoom=3&hl=en&sig=ACfU3U38JHR
				id=b1slEAAAQBAJ&pg=RA2-PA174&img=1&zoom=3&hl=en&sig=ACfU3U0bVs2
				id=b1slEAAAQBAJ&pg=RA2-PA175&img=1&zoom=3&hl=en&sig=ACfU3U3X9Y5
				id=b1slEAAAQBAJ&pg=RA2-PA176&img=1&zoom=3&hl=en&sig=ACfU3U2n-k4
				id=b1slEAAAQBAJ&pg=RA2-PA177&img=1&zoom=3&hl=en&sig=ACfU3U2KzXY
			index Z
				id=b1slEAAAQBAJ&pg=RA2-PA178&img=1&zoom=3&hl=en&sig=ACfU3U0kTNh
				id=b1slEAAAQBAJ&pg=RA2-PA179&img=1&zoom=3&hl=en&sig=ACfU3U1ktJ2
				id=b1slEAAAQBAJ&pg=RA2-PA180&img=1&zoom=3&hl=en&sig=ACfU3U2b8-T
				id=b1slEAAAQBAJ&pg=RA2-PA181&img=1&zoom=3&hl=en&sig=ACfU3U1JR3r
				id=b1slEAAAQBAJ&pg=RA2-PA182&img=1&zoom=3&hl=en&sig=ACfU3U2UV4X
				id=b1slEAAAQBAJ&pg=RA2-PA183&img=1&zoom=3&hl=en&sig=ACfU3U1XhgM
				id=b1slEAAAQBAJ&pg=RA2-PA184&img=1&zoom=3&hl=en&sig=ACfU3U1ytZu
				id=b1slEAAAQBAJ&pg=RA2-PA185&img=1&zoom=3&hl=en&sig=ACfU3U29Pch
				id=b1slEAAAQBAJ&pg=RA2-PA186&img=1&zoom=3&hl=en&sig=ACfU3U2-fjD
				id=b1slEAAAQBAJ&pg=RA2-PA187&img=1&zoom=3&hl=en&sig=ACfU3U0xIPG
				id=b1slEAAAQBAJ&pg=RA2-PA188&img=1&zoom=3&hl=en&sig=ACfU3U3Z3i5
				id=b1slEAAAQBAJ&pg=RA2-PA189&img=1&zoom=3&hl=en&sig=ACfU3U0nexh
				id=b1slEAAAQBAJ&pg=RA2-PA190&img=1&zoom=3&hl=en&sig=ACfU3U1sB7w
				id=b1slEAAAQBAJ&pg=RA2-PA191&img=1&zoom=3&hl=en&sig=ACfU3U2J1fe
				id=b1slEAAAQBAJ&pg=RA2-PA192&img=1&zoom=3&hl=en&sig=ACfU3U0mWUl
				id=b1slEAAAQBAJ&pg=RA2-PA193&img=1&zoom=3&hl=en&sig=ACfU3U2kf9P
				id=b1slEAAAQBAJ&pg=RA2-PA194&img=1&zoom=3&hl=en&sig=ACfU3U3DB50
				id=b1slEAAAQBAJ&pg=RA2-PA195&img=1&zoom=3&hl=en&sig=ACfU3U1gArM
				id=b1slEAAAQBAJ&pg=RA2-PA196&img=1&zoom=3&hl=en&sig=ACfU3U38-L-
				id=b1slEAAAQBAJ&pg=RA2-PA197&img=1&zoom=3&hl=en&sig=ACfU3U2BptM
				id=b1slEAAAQBAJ&pg=RA2-PA198&img=1&zoom=3&hl=en&sig=ACfU3U1lqNz
				id=b1slEAAAQBAJ&pg=RA2-PA199&img=1&zoom=3&hl=en&sig=ACfU3U24RGT
				id=b1slEAAAQBAJ&pg=RA2-PA200&img=1&zoom=3&hl=en&sig=ACfU3U0bVPN
				id=b1slEAAAQBAJ&pg=RA2-PA201&img=1&zoom=3&hl=en&sig=ACfU3U3720K
				id=b1slEAAAQBAJ&pg=RA2-PA202&img=1&zoom=3&hl=en&sig=ACfU3U3qokz
				id=b1slEAAAQBAJ&pg=RA2-PA203&img=1&zoom=3&hl=en&sig=ACfU3U3M4Gb
				id=b1slEAAAQBAJ&pg=RA2-PA204&img=1&zoom=3&hl=en&sig=ACfU3U0-VWE
				id=b1slEAAAQBAJ&pg=RA2-PA205&img=1&zoom=3&hl=en&sig=ACfU3U2wZM7
				id=b1slEAAAQBAJ&pg=RA2-PA206&img=1&zoom=3&hl=en&sig=ACfU3U0u569
				id=b1slEAAAQBAJ&pg=RA2-PA207&img=1&zoom=3&hl=en&sig=ACfU3U0eclh
				id=b1slEAAAQBAJ&pg=RA2-PA208&img=1&zoom=3&hl=en&sig=ACfU3U2fAzn
				id=b1slEAAAQBAJ&pg=RA2-PA209&img=1&zoom=3&hl=en&sig=ACfU3U1bUnn
				id=b1slEAAAQBAJ&pg=RA2-PA210&img=1&zoom=3&hl=en&sig=ACfU3U3Cvtp
				id=b1slEAAAQBAJ&pg=RA2-PA211&img=1&zoom=3&hl=en&sig=ACfU3U0ANVz
				id=b1slEAAAQBAJ&pg=RA2-PA212&img=1&zoom=3&hl=en&sig=ACfU3U3IatD
				id=b1slEAAAQBAJ&pg=RA2-PA213&img=1&zoom=3&hl=en&sig=ACfU3U14UpL
				id=b1slEAAAQBAJ&pg=RA2-PA214&img=1&zoom=3&hl=en&sig=ACfU3U3mlgc
				id=b1slEAAAQBAJ&pg=RA2-PA215&img=1&zoom=3&hl=en&sig=ACfU3U0fN_h
				id=b1slEAAAQBAJ&pg=RA2-PA216&img=1&zoom=3&hl=en&sig=ACfU3U3R5Mt
				id=b1slEAAAQBAJ&pg=RA2-PA217&img=1&zoom=3&hl=en&sig=ACfU3U052Pp
				id=b1slEAAAQBAJ&pg=RA2-PA218&img=1&zoom=3&hl=en&sig=ACfU3U2H072
				id=b1slEAAAQBAJ&pg=RA2-PA219&img=1&zoom=3&hl=en&sig=ACfU3U3MNPN
				id=b1slEAAAQBAJ&pg=RA2-PA220&img=1&zoom=3&hl=en&sig=ACfU3U1r3Sl
				id=b1slEAAAQBAJ&pg=RA2-PA221&img=1&zoom=3&hl=en&sig=ACfU3U342dU
				id=b1slEAAAQBAJ&pg=RA2-PA222&img=1&zoom=3&hl=en&sig=ACfU3U25yqS
				id=b1slEAAAQBAJ&pg=RA2-PA223&img=1&zoom=3&hl=en&sig=ACfU3U0kFBL
				id=b1slEAAAQBAJ&pg=RA2-PA224&img=1&zoom=3&hl=en&sig=ACfU3U3qo9g
				id=b1slEAAAQBAJ&pg=RA2-PA225&img=1&zoom=3&hl=en&sig=ACfU3U3kSHl
				id=b1slEAAAQBAJ&pg=RA2-PA226&img=1&zoom=3&hl=en&sig=ACfU3U14XJ_
				id=b1slEAAAQBAJ&pg=RA2-PA227&img=1&zoom=3&hl=en&sig=ACfU3U182Jn
				id=b1slEAAAQBAJ&pg=RA2-PA228&img=1&zoom=3&hl=en&sig=ACfU3U1QgTI
				id=b1slEAAAQBAJ&pg=RA2-PA229&img=1&zoom=3&hl=en&sig=ACfU3U3KyF9
	blank.pdf (p.2876)
04